{"id":"coronavac-biofarma-covid-19-vaccine","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Injection site pain or swelling"},{"rate":"5-15","effect":"Fatigue"},{"rate":"5-15","effect":"Headache"},{"rate":"5-15","effect":"Myalgia"},{"rate":"5-10","effect":"Fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains chemically inactivated SARS-CoV-2 virus particles that cannot cause infection but retain antigenic properties. When administered, these particles trigger both humoral (antibody) and cell-mediated immune responses, priming the immune system to recognize and neutralize live virus upon exposure. This approach has been used successfully in other viral vaccines such as polio and hepatitis A.","oneSentence":"CoronaVac is an inactivated whole-virus COVID-19 vaccine that stimulates the immune system to produce antibodies and cellular immunity against SARS-CoV-2.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:49.047Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 prevention in adults"}]},"trialDetails":[{"nctId":"NCT05918939","phase":"EARLY_PHASE1","title":"UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)","status":"UNKNOWN","sponsor":"Dr. Soetomo General Hospital","startDate":"2022-09-05","conditions":"COVID-19 Pandemic, COVID-19 Vaccines","enrollment":350},{"nctId":"NCT05226429","phase":"PHASE1, PHASE2","title":"UNAIR Inactivated COVID-19 Vaccine","status":"UNKNOWN","sponsor":"Dr. Soetomo General Hospital","startDate":"2022-02-08","conditions":"COVID-19 Pandemic, Vaccine Reaction","enrollment":495},{"nctId":"NCT05508477","phase":"PHASE3","title":"UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)","status":"UNKNOWN","sponsor":"Dr. Soetomo General Hospital","startDate":"2022-06-28","conditions":"COVID-19 Pandemic, COVID-19 Vaccines","enrollment":4005}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"CoronaVac Biofarma COVID-19 Vaccine","genericName":"CoronaVac Biofarma COVID-19 Vaccine","companyName":"Dr. Soetomo General Hospital","companyId":"dr-soetomo-general-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"CoronaVac is an inactivated whole-virus COVID-19 vaccine that stimulates the immune system to produce antibodies and cellular immunity against SARS-CoV-2. Used for COVID-19 prevention in adults.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}